SynthesisFrontiers in oncology2026

Efficacy and safety of PARP inhibitors in older patients with advanced ovarian cancer: a systematic review and network meta-analysis.

Lei Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.